| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/25/2009 | CN101391099A Use of growth hormone releasing peptides sustained release preparation in promoting fur-bearing animal grow |
| 03/25/2009 | CN101391098A Apitoxin liposome preparation and preparation method thereof |
| 03/25/2009 | CN101390969A Medicine capable of reducing uric acid content in blood |
| 03/25/2009 | CN101390965A Veterinary traditional Chinese herb medicine for treating livestock and poultry bacterial and viral infectious diseases and preparation method thereof |
| 03/25/2009 | CN101390873A Cytidine disodium triphosphate and arginine composition and preparation method thereof |
| 03/25/2009 | CN101390865A Anticancer composition containing lurtolecan |
| 03/25/2009 | CN101390862A Medicine composition containing mizolastine and preparation method thereof |
| 03/25/2009 | CN101390861A Solid medicine composition containing voriconazole |
| 03/25/2009 | CN101390859A Medicine composition containing omeprazole and domperidone |
| 03/25/2009 | CN101390857A Medicine composition containing lansoprazole |
| 03/25/2009 | CN101390856A Solid preparation of clopidogrel and preparation method thereof |
| 03/25/2009 | CN101390854A Medical composition containing riluzole |
| 03/25/2009 | CN101390848A Medicine composition azithromycin enteric-coated capsules and preparation method thereof |
| 03/25/2009 | CN101390839A Policosanol drop pill and preparation method thereof |
| 03/25/2009 | CN101390836A Antifungal activity ophthalmopathy slow-release microparticle and use thereof |
| 03/25/2009 | CN101390833A Anti-cancer slow-release formulation loaded with carmustine and synergist thereof |
| 03/25/2009 | CN101390832A Anti-cancer slow-release formulation loaded with carmustine and fluorouracil |
| 03/25/2009 | CN101390831A Docetaxel medical composition for injection and preparation method thereof |
| 03/25/2009 | CN101390829A Anticancer composition loaded with anti-metabolism medicine fluorouracil and synergist thereof |
| 03/25/2009 | CN101390828A Anticancer composition loaded with anti-metabolism medicine and synergist thereof |
| 03/25/2009 | CN101390827A Sustained-release injection containing methotrexate synergist |
| 03/25/2009 | CN101390826A Magnetic tumour target polymer nano vesicle and preparation method thereof |
| 03/25/2009 | CN101390825A Intra-ocular release system of voriconazole |
| 03/25/2009 | CN101390823A Medical composition containing quetiapine |
| 03/25/2009 | CN100472213C Detection and treatment of cancer |
| 03/25/2009 | CN100471957C Adenovirus vectors for immunotherapy |
| 03/25/2009 | CN100471886C Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery |
| 03/25/2009 | CN100471874C Superabsorber, method for prodn. and use thereof |
| 03/25/2009 | CN100471522C Polynucleotide compsn. method of prepn. and use thereof |
| 03/25/2009 | CN100471521C Polypeptides having single covalently bound N-terminal water-soluble polymer |
| 03/25/2009 | CN100471501C Treatment and prophylaxis of diseases and infections of pigs and poultry |
| 03/25/2009 | CN100471496C Inclusion containing raltitrexed and its powder injection |
| 03/25/2009 | CN100471491C Toluene sulfonamide-containing anti-tumor composition and method of use thereof |
| 03/25/2009 | CN100471489C Soft capsule containing Lamiophlomis rotata Kudo. root extract |
| 03/25/2009 | CN100471486C Immunomodulatory compositions, methods of making, and methods of use thereof |
| 03/24/2009 | US7507790 Plurality of peptide monomers each being attached at one end to a hub capable of interacting with a sub-unit of a self-assembling peptide to form an overlapping staggered structure or protein; purification of blood or biological fluids, cell assembly and tissue engineering |
| 03/24/2009 | US7507764 Amphiphilic [5:1]- and [3:3]- hexakisadducts of fullerenes |
| 03/24/2009 | US7507762 Substituted 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/24/2009 | US7507725 Compounds with sulphonamide group and pharmaceutical compositions containing these compounds |
| 03/24/2009 | US7507546 Using intestinal peptide transporter (PEPT1) and/or kidney peptide transporter (PEPT2) to identify modulators which prevent transfer of sarcosine-glycine dipeptide across cells; drug delivery |
| 03/24/2009 | US7507537 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 03/24/2009 | US7507530 Nanoparticle complexes having a defined number of ligands |
| 03/24/2009 | US7507421 From aqueous extract of Garcinia cambogia/indica fruits; tasteless; for use in foods |
| 03/24/2009 | US7507420 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 03/24/2009 | US7507419 Topically applied Clostridium botulinum toxin compositions and treatment methods |
| 03/24/2009 | US7507414 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 03/24/2009 | US7507412 for drug screening; kits for collagen and/or platelet-collagen interaction; for treatment of thrombotic and cardiovascular events and disorders |
| 03/24/2009 | US7507407 Immunoliposomes that optimize internationalization into target cells |
| 03/24/2009 | US7507406 administering immunoglobulins linked to proteins having amino acid replacements in the amino acid sequence, to increase the circulating half-life in vivo than a corresponding antibody-based fusion proteins without amino acid replacements; reducing tumor size and metastasis in mammals |
| 03/24/2009 | US7507402 Topical use of probiotic Bacillus spores to prevent or control microbial infections |
| 03/24/2009 | US7507398 Using condensation aerosol (MMAD of less than 5 microns) formed by vaporizing a thin layer of the drug on a solid support and condensing the vapor to treat anxiety, vertigo, alcohol or nicotine withdrawal, sedation, hot flashes, peptic ulcers or for hormone replacement therapy, or pregnancy prevention |
| 03/24/2009 | US7507397 Delivery of muscle relaxants through an inhalation route |
| 03/24/2009 | CA2520979C Formulations of ecteinascidins |
| 03/24/2009 | CA2508897C Process for manufacture of a composition for supplementing animals with solutions of essential metal amino acid complexes |
| 03/24/2009 | CA2487586C Feed supplemented with ketoprofen and its use in the simultaneous treatment of conditions causing fever, inflammation and/or pain in a herd of animals |
| 03/24/2009 | CA2450690C Improved chelator conjugates |
| 03/24/2009 | CA2390558C Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and agents containing the same |
| 03/24/2009 | CA2352211C Sustained release matrix systems for highly soluble drugs |
| 03/24/2009 | CA2338703C Injectable aqueous dispersions of propofol |
| 03/24/2009 | CA2328136C Intramolecularly-quenched near infrared fluorescent probes |
| 03/24/2009 | CA2267456C Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 03/24/2009 | CA2264626C Pharmaceutical composition containing lornoxicam and a disodium salt of edta |
| 03/24/2009 | CA2215997C Biodegradable polyacetal polymers and formation and use |
| 03/23/2009 | CA2701047A1 Antibody against anthrax toxins |
| 03/21/2009 | CA2602828A1 Method for oil and byproduct extraction and distribution |
| 03/19/2009 | WO2009036092A2 Mitochondria-targeted anti-tumour agents |
| 03/19/2009 | WO2009035438A1 Polymeric nanoparticles by ion-ion interactions |
| 03/19/2009 | WO2009035174A1 Composition for treating or preventing atopic dermatitis comprising poly-gamma-glutamic acid |
| 03/19/2009 | WO2009035173A1 Composition for preventing virus infection comprising poly-gamma-glutamic acid |
| 03/19/2009 | WO2009035092A1 Novel polypeptide and production method thereof |
| 03/19/2009 | WO2009035070A1 Transdermally absorbable preparation and transdermally absorbable system using the same |
| 03/19/2009 | WO2009035034A1 Ophthalmic composition |
| 03/19/2009 | WO2009035033A1 Ophthalmic composition |
| 03/19/2009 | WO2009034980A1 Process for producing biological ingesta and biological ingesta obtained thereby |
| 03/19/2009 | WO2009034958A1 Protein stabilizer, method for producing the same, method for using protein stabilizer, and method for stabilizing protein |
| 03/19/2009 | WO2009034604A1 Liquid crystal emulsion-type pharmaceutical composition containing cyclosporine, and method of treating cutaneous disease therewith |
| 03/19/2009 | WO2009034171A1 Pharmaceutical compositions for oral use for treating patients affected by obesity |
| 03/19/2009 | WO2009034136A2 Pharmaceutical compound |
| 03/19/2009 | WO2009034118A1 Stable formulations of amylin and its analogues |
| 03/19/2009 | WO2009033406A1 Modified recombinant human endostatin and its application |
| 03/19/2009 | WO2009033259A1 An anti-cancer cytotoxic monoclonal antibody |
| 03/19/2009 | WO2009033204A1 Multi-component compositions and methods for delivery of anti-cancer agents |
| 03/19/2009 | WO2009017823A3 A fold-back diabody diphtheria toxin immunotoxin and methods of use |
| 03/19/2009 | WO2009016069A3 Stable liquid pharmaceutical composition based on trazodone |
| 03/19/2009 | WO2009013448A3 Herpesviruses having altered target cell specificity |
| 03/19/2009 | WO2009013261A3 Derivatised polysaccharide material for the topic antibacterial activity |
| 03/19/2009 | WO2009001144A3 Pharmaceutical aerosol compositions comprising fluticasone |
| 03/19/2009 | WO2008156904A3 Systems and methods for nanomagnetic actuation of molecular cell signaling |
| 03/19/2009 | WO2008152226A3 Homogeneous and stable composition rich in oleaginous substances based on a milk product, method for the preparation thereof and uses thereof |
| 03/19/2009 | WO2008139467A3 Lipid conjugated cyclic carbonate derivatives, their synthesis, and uses |
| 03/19/2009 | WO2008139229A3 Pores |
| 03/19/2009 | WO2008131419A3 Glycoconjugates of rna interference agents |
| 03/19/2009 | WO2008065492A3 A composition for the administration of biologically active principles in gynaecologic and rectal field and uses thereof |
| 03/19/2009 | WO2008017507A3 Nanoparticle nucleic acid bonding compound conjugates forming i-motifs |
| 03/19/2009 | WO2005101993A3 Metal-containing nanolayered composites, and applications thereof |
| 03/19/2009 | US20090076595 Medical devices having bioerodable layers for the release of therapeutic agents |
| 03/19/2009 | US20090076257 Ester Derivatives of Hyaluronic Acid for the Preparation of Hydrogel Materials by Photocuring |
| 03/19/2009 | US20090076177 Tamper resistant lipid-based oral dosage form for opioid agonists |
| 03/19/2009 | US20090076176 Prodrugs activated by plasmin and their use in cancer chemotherapy |
| 03/19/2009 | US20090076174 Control release of biologically active compounds from multi-armed oligomers |